Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pimbio develops and commercializes advanced microfluidic devices under the PimCell brand, enabling researchers to create physiologically relevant living tissue models such as brain organoids. Their patented technology addresses limitations of existing microfluidic systems by supporting larger, vascularized 3D tissues with improved perfusion. The products are intended to accelerate drug discovery and biomedical research by providing ready-to-use, customizable organ-on-a-chip solutions[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pimbio.